Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 5 | 2022 | 700 | 1.380 |
Why?
|
| Hypertension | 7 | 2011 | 1535 | 0.920 |
Why?
|
| Office Visits | 3 | 2020 | 83 | 0.850 |
Why?
|
| Gonorrhea | 1 | 2022 | 50 | 0.790 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2022 | 29 | 0.770 |
Why?
|
| Transgender Persons | 1 | 2020 | 15 | 0.710 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 135 | 0.710 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 300 | 0.660 |
Why?
|
| Coronary Disease | 3 | 2011 | 358 | 0.650 |
Why?
|
| Coronary Artery Disease | 4 | 2012 | 696 | 0.640 |
Why?
|
| Physician-Patient Relations | 2 | 2017 | 261 | 0.620 |
Why?
|
| Health Education | 1 | 2020 | 279 | 0.600 |
Why?
|
| Group Processes | 1 | 2017 | 42 | 0.590 |
Why?
|
| Quality of Health Care | 1 | 2020 | 322 | 0.570 |
Why?
|
| Acute Disease | 1 | 2018 | 658 | 0.570 |
Why?
|
| Anxiety Disorders | 2 | 2011 | 426 | 0.550 |
Why?
|
| Internet | 1 | 2018 | 390 | 0.520 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1536 | 0.500 |
Why?
|
| Family Practice | 1 | 2017 | 312 | 0.500 |
Why?
|
| Physicians | 1 | 2017 | 324 | 0.460 |
Why?
|
| HIV Infections | 1 | 2022 | 791 | 0.460 |
Why?
|
| Chlamydophila Infections | 1 | 2012 | 6 | 0.430 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2012 | 13 | 0.430 |
Why?
|
| Adult | 21 | 2022 | 21403 | 0.430 |
Why?
|
| Clinical Competence | 1 | 2017 | 657 | 0.420 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2010 | 147 | 0.410 |
Why?
|
| Internship and Residency | 1 | 2017 | 596 | 0.400 |
Why?
|
| Environmental Pollutants | 2 | 2010 | 180 | 0.400 |
Why?
|
| Humans | 37 | 2022 | 68618 | 0.390 |
Why?
|
| Vascular Calcification | 1 | 2012 | 131 | 0.380 |
Why?
|
| Insulin Resistance | 2 | 2010 | 241 | 0.370 |
Why?
|
| Prediabetic State | 1 | 2011 | 48 | 0.370 |
Why?
|
| Primary Health Care | 7 | 2022 | 703 | 0.360 |
Why?
|
| Albuminuria | 1 | 2011 | 171 | 0.360 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 163 | 0.340 |
Why?
|
| Gastrointestinal Agents | 1 | 2010 | 51 | 0.340 |
Why?
|
| Female | 26 | 2022 | 38074 | 0.340 |
Why?
|
| Male | 26 | 2022 | 37321 | 0.340 |
Why?
|
| Hepatitis B Antibodies | 1 | 2008 | 8 | 0.330 |
Why?
|
| Middle Aged | 21 | 2022 | 21147 | 0.320 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 130 | 0.320 |
Why?
|
| Hepatitis C Antibodies | 1 | 2008 | 19 | 0.320 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 136 | 0.320 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 87 | 0.320 |
Why?
|
| Environmental Exposure | 1 | 2010 | 269 | 0.310 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 137 | 0.310 |
Why?
|
| Gastroesophageal Reflux | 2 | 2011 | 318 | 0.310 |
Why?
|
| Insulin | 3 | 2010 | 619 | 0.300 |
Why?
|
| Risk Factors | 12 | 2014 | 5731 | 0.300 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 292 | 0.280 |
Why?
|
| Drug Utilization Review | 1 | 2006 | 19 | 0.280 |
Why?
|
| Comorbidity | 5 | 2012 | 1426 | 0.270 |
Why?
|
| Risk Assessment | 5 | 2015 | 2007 | 0.270 |
Why?
|
| Mobile Applications | 2 | 2018 | 138 | 0.260 |
Why?
|
| Cross-Sectional Studies | 6 | 2016 | 2279 | 0.260 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 1085 | 0.250 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 940 | 0.240 |
Why?
|
| Pilot Projects | 3 | 2022 | 1342 | 0.240 |
Why?
|
| Alcohol Drinking | 2 | 2010 | 805 | 0.240 |
Why?
|
| Ambulatory Care | 2 | 2022 | 340 | 0.240 |
Why?
|
| Aged | 13 | 2014 | 14862 | 0.220 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2011 | 504 | 0.220 |
Why?
|
| United States | 9 | 2012 | 7367 | 0.210 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 498 | 0.210 |
Why?
|
| Smoking Cessation | 2 | 2022 | 1034 | 0.210 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 694 | 0.210 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 34 | 0.200 |
Why?
|
| Preventive Health Services | 1 | 2022 | 86 | 0.190 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 807 | 0.190 |
Why?
|
| Southeastern United States | 1 | 2022 | 281 | 0.190 |
Why?
|
| Depression | 2 | 2018 | 943 | 0.190 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 378 | 0.180 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 207 | 0.170 |
Why?
|
| Educational Status | 1 | 2020 | 273 | 0.170 |
Why?
|
| Logistic Models | 5 | 2011 | 1420 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 136 | 0.160 |
Why?
|
| Young Adult | 6 | 2018 | 5717 | 0.160 |
Why?
|
| Medication Adherence | 1 | 2022 | 335 | 0.160 |
Why?
|
| Cancer Survivors | 1 | 2020 | 146 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.150 |
Why?
|
| Medical Records | 2 | 2008 | 121 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2012 | 3705 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2010 | 880 | 0.140 |
Why?
|
| Disease Progression | 2 | 2012 | 1038 | 0.140 |
Why?
|
| Prognosis | 2 | 2012 | 2093 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2017 | 392 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 581 | 0.140 |
Why?
|
| Alcohol Drinking in College | 1 | 2016 | 13 | 0.130 |
Why?
|
| Athletes | 1 | 2016 | 40 | 0.130 |
Why?
|
| Adolescent | 5 | 2018 | 8912 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4848 | 0.130 |
Why?
|
| Communication | 1 | 2017 | 329 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2015 | 44 | 0.120 |
Why?
|
| Health Surveys | 4 | 2010 | 489 | 0.120 |
Why?
|
| Universities | 1 | 2016 | 191 | 0.120 |
Why?
|
| Psychotherapy | 1 | 2017 | 253 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2017 | 297 | 0.120 |
Why?
|
| Obesity | 3 | 2012 | 1076 | 0.120 |
Why?
|
| C-Reactive Protein | 3 | 2010 | 180 | 0.120 |
Why?
|
| South Carolina | 2 | 2017 | 2752 | 0.110 |
Why?
|
| Counseling | 1 | 2015 | 280 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2020 | 374 | 0.110 |
Why?
|
| Aspirin | 1 | 2014 | 295 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2800 | 0.100 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 90 | 0.100 |
Why?
|
| Stress, Psychological | 2 | 2010 | 824 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 373 | 0.100 |
Why?
|
| Electronics | 2 | 2022 | 25 | 0.100 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 10 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2020 | 7277 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2015 | 413 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 77 | 0.090 |
Why?
|
| Catecholamines | 1 | 2011 | 73 | 0.090 |
Why?
|
| Arginine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Causality | 2 | 2008 | 82 | 0.090 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2011 | 88 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2011 | 150 | 0.090 |
Why?
|
| Panic Disorder | 1 | 2011 | 121 | 0.090 |
Why?
|
| Arousal | 1 | 2011 | 168 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2011 | 88 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2008 | 274 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2011 | 91 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2011 | 132 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 107 | 0.090 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2010 | 38 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 88 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 772 | 0.090 |
Why?
|
| Leukocytes | 1 | 2009 | 99 | 0.080 |
Why?
|
| Telomere | 1 | 2009 | 59 | 0.080 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.080 |
Why?
|
| Health Behavior | 3 | 2018 | 458 | 0.080 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 711 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 579 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 240 | 0.080 |
Why?
|
| Fasting | 1 | 2008 | 75 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 177 | 0.080 |
Why?
|
| Urban Population | 1 | 2010 | 255 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 287 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2008 | 242 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 362 | 0.080 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2008 | 22 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2008 | 114 | 0.080 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 69 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 338 | 0.070 |
Why?
|
| Alcoholism | 1 | 2016 | 1109 | 0.070 |
Why?
|
| Anger | 1 | 2007 | 47 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 100 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2008 | 1451 | 0.070 |
Why?
|
| Smoking | 2 | 2012 | 1452 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2011 | 718 | 0.070 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2006 | 8 | 0.070 |
Why?
|
| Age Distribution | 1 | 2008 | 320 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2008 | 239 | 0.070 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 32 | 0.070 |
Why?
|
| Age Factors | 2 | 2009 | 1864 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 95 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 90 | 0.070 |
Why?
|
| Rural Population | 1 | 2010 | 398 | 0.070 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 82 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 138 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 189 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 202 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 258 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2007 | 737 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 212 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2008 | 2358 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2022 | 652 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2011 | 1506 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 298 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 1753 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 256 | 0.040 |
Why?
|
| ROC Curve | 2 | 2008 | 392 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1553 | 0.030 |
Why?
|
| Motivation | 1 | 2020 | 561 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2008 | 208 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 454 | 0.030 |
Why?
|
| Stroke | 1 | 2008 | 2163 | 0.030 |
Why?
|
| Biomarkers | 2 | 2011 | 1593 | 0.030 |
Why?
|
| Trust | 1 | 2015 | 75 | 0.030 |
Why?
|
| Animals | 1 | 2010 | 20881 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2014 | 249 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 191 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2011 | 14 | 0.020 |
Why?
|
| Dinoprost | 1 | 2011 | 27 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 53 | 0.020 |
Why?
|
| Nitrates | 1 | 2011 | 61 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 2011 | 37 | 0.020 |
Why?
|
| Esophagitis | 1 | 2011 | 45 | 0.020 |
Why?
|
| Barrett Esophagus | 1 | 2011 | 57 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 260 | 0.020 |
Why?
|
| Mass Screening | 1 | 2016 | 843 | 0.020 |
Why?
|
| Serum | 1 | 2010 | 24 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 563 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 174 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 281 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 219 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 123 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2008 | 59 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 130 | 0.020 |
Why?
|
| Calcinosis | 1 | 2009 | 241 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 621 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2006 | 113 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 792 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 117 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 291 | 0.020 |
Why?
|
| Exercise Test | 1 | 2006 | 242 | 0.020 |
Why?
|
| Cholesterol | 1 | 2006 | 331 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 345 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 867 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3259 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|